{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:01:18Z","timestamp":1791025278327,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,8,24]],"date-time":"2010-08-24T00:00:00Z","timestamp":1282608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00198-010-1327-x","type":"journal-article","created":{"date-parts":[[2010,8,23]],"date-time":"2010-08-23T16:20:22Z","timestamp":1282580422000},"page":"577-585","source":"Crossref","is-referenced-by-count":26,"title":["Osteopontin regulates anabolic effect in human menopausal osteoporosis with intermittent parathyroid hormone treatment"],"prefix":"10.1007","volume":"22","author":[{"given":"T.-I.","family":"Chiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.-C.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.-S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-H.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-W.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,24]]},"reference":[{"key":"1327_CR1","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.yexcr.2006.06.003","volume":"312","author":"M Ishijima","year":"2006","unstructured":"Ishijima M, Ezura Y, Kunikazu T, Rittling SR, Kurosawa H, Denhardt DT, Emi M, Nifuji A, Noda M (2006) Osteopontin during tail-suspension-induced bone loss. Exp Cell Res 312:3075\u20133083","journal-title":"Exp Cell Res"},{"key":"1327_CR2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1210\/jc.86.3.957","volume":"86","author":"CJ Rosen","year":"2001","unstructured":"Rosen CJ, Bilezikian JP (2001) Clinical review 123: anabolic therapy for osteoporosis. J Clin Endocrinol Metab 86:957\u2013964","journal-title":"J Clin Endocrinol Metab"},{"key":"1327_CR3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1043-2760(01)00460-X","volume":"12","author":"E Seeman","year":"2001","unstructured":"Seeman E, Delmas PD (2001) Reconstructing the skeletion with intermittent parathyroid hormone. Trends Endocrinol Metab 12:281\u2013283","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"1327_CR4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00223-006-0108-1","volume":"79","author":"J Fox","year":"2006","unstructured":"Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY (2006) Daily treatment of aged ovariectomized rats with human parathyroid hormone (1\u201384) for 12\u00a0months reverses bone loss and enhances trabecular and cortical bone strength. Calcif Tissue Int 79(4):262\u2013272","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"1327_CR5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bone.2008.09.019","volume":"44","author":"RR Recker","year":"2008","unstructured":"Recker RR, Bare SP, Smith SY, Varela A, Miller MA, Morris SA, Fox J (2008) Cancellous and cortical bone architecture and turnover at the iliac crest of postmenopausal osteoporotic women treated with parathyroid hormone 1\u201384. Bone 44(1):113\u2013119","journal-title":"Bone"},{"issue":"6","key":"1327_CR6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/MED.0b013e32831a46d6","volume":"15","author":"F Cosman","year":"2008","unstructured":"Cosman F (2008) Parathyroid hormone treatment for osteoporosis. Curr Opin Endocrinol Diabetes Obes 15(6):495\u2013501","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"1327_CR7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0945-053X(00)00050-0","volume":"19","author":"S Nomura","year":"2000","unstructured":"Nomura S, Takano-Yamamoto T (2000) Molecular events caused by mechanical stress in bone. Matrix Biol 19(2):91\u201396","journal-title":"Matrix Biol"},{"issue":"5","key":"1327_CR8","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1210\/en.2002-220996","volume":"144","author":"K Kitahara","year":"2003","unstructured":"Kitahara K, Ishijima M, Rittling SR, Tsuji K, Kurosawa H, Nifuji A, Denhardt DT, Noda M (2003) Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation. Endocrinology 144(5):2132\u20132140","journal-title":"Endocrinology"},{"key":"1327_CR9","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1359\/jbmr.1998.13.7.1101","volume":"13","author":"SR Rittling","year":"1998","unstructured":"Rittling SR, Matsumoto HN, Mckee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT (1998) Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 13:1101\u20131111","journal-title":"J Bone Miner Res"},{"key":"1327_CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000020591","volume":"7","author":"SR Rittling","year":"1999","unstructured":"Rittling SR, Denhardt DT (1999) Osteopontin function in pathology: lessons from osteopontin-deficient mice. Exp Nephrol 7:103\u2013113","journal-title":"Exp Nephrol"},{"key":"1327_CR11","doi-asserted-by":"crossref","first-page":"8156","DOI":"10.1073\/pnas.96.14.8156","volume":"96","author":"H Yoshitake","year":"1999","unstructured":"Yoshitake H, Rittling SR, Denhardt DT, Noda M (1999) Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 96:8156\u20138160","journal-title":"Proc Natl Acad Sci USA"},{"key":"1327_CR12","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1210\/en.142.3.1325","volume":"142","author":"Y Asou","year":"2001","unstructured":"Asou Y, Rittling SR, Yoshitake H, Tsuji K, Shinomiya K, Nifuji A, Denhardt DT, Noda M (2001) Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone. Endocrinology 142:1325\u20131332","journal-title":"Endocrinology"},{"key":"1327_CR13","doi-asserted-by":"crossref","first-page":"13065","DOI":"10.1074\/jbc.M010938200","volume":"276","author":"H Ihara","year":"2001","unstructured":"Ihara H, Denhardt DT, Furuya K, Yamashita T, Muguruma Y, Tsuji K, Hruska KA, Higashio K, Enomoto S, Nifuji A, Rittling SR, Noda M (2001) Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin. J Biol Chem 276:13065\u201313071","journal-title":"J Biol Chem"},{"key":"1327_CR14","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1073\/pnas.052523599","volume":"99","author":"K Yumoto","year":"2002","unstructured":"Yumoto K, Ishijima M, Rittling SR, Tsuji K, Tsuchiya Y, Kon S, Nifuji A, Uede T, Denhardt DT, Noda M (2002) Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci USA 99:4556\u20134561","journal-title":"Proc Natl Acad Sci USA"},{"key":"1327_CR15","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1359\/jbmr.2003.18.9.1706","volume":"18","author":"M Morinobu","year":"2003","unstructured":"Morinobu M, Ishijima M, Rittling SR, Tsuji K, Yamamoto H, Nifuji A, Denhardt DT, Noda M (2003) Osteopontin expression in osteoblasts and osteocytes during bone formation under mechanical stress in the calvarial suture in vivo. J Bone Miner Res 18:1706\u20131715","journal-title":"J Bone Miner Res"},{"key":"1327_CR16","doi-asserted-by":"crossref","first-page":"24871","DOI":"10.1016\/S0021-9258(18)35844-7","volume":"267","author":"Y Chen","year":"1992","unstructured":"Chen Y, Bal BS, Gorski JP (1992) Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J Boil Chem 267:24871\u201324878","journal-title":"J Boil Chem"},{"key":"1327_CR17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1749-6632.1995.tb44636.x","volume":"760","author":"JR Hoyer","year":"1995","unstructured":"Hoyer JR, Otvos L Jr, Urge L (1995) Osteopontin in urinary stone formation. Ann N Y Acad Sci 760:257\u2013265","journal-title":"Ann N Y Acad Sci"},{"key":"1327_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03008209509016974","volume":"33","author":"RL MacNeli","year":"1995","unstructured":"MacNeli RL, Berry J, D\u2019ErricoJ SC, Piotrowski B, Somerman MJ (1995) Role of two mineral-associated adhesion molecules, osteopontin and bone sialoprotein, during cementogenesis. Connect Tissue Res 33:1\u20137","journal-title":"Connect Tissue Res"},{"key":"1327_CR19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1749-6632.1995.tb44630.x","volume":"760","author":"MA Horton","year":"1995","unstructured":"Horton MA, Nesbit MA, Helfrich MH (1995) Interaction of osteopontin with osteoclast integrins. Ann N Y Acad Sci 760:190\u2013200","journal-title":"Ann N Y Acad Sci"},{"key":"1327_CR20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1749-6632.1995.tb44624.x","volume":"760","author":"CM Giachelli","year":"1995","unstructured":"Giachelli CM, Liaw L, Murry CE, Schwartz S, Almeida MM (1995) Osteopontin expression in cardiovascular diseases. Ann N Y Acad Sci 760:109\u2013126","journal-title":"Ann N Y Acad Sci"},{"key":"1327_CR21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/01.ATV.17.1.188","volume":"17","author":"L Liaw","year":"1997","unstructured":"Liaw L, Lombardi DM, Almeida MM, Schwartz SM, DeBlois D, Giachelli CM (1997) Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. Arterioscler Thromb Vasc Biol 17:188\u2013193","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1327_CR22","first-page":"317","volume":"21","author":"R Pichler","year":"1995","unstructured":"Pichler R, Giachelli CM, Young B, Alpers CE, Couser WG, Johnson RJ (1995) The pathogenesis of tubulointerstitial disease associated with glomerulonephritis: the glomerular cytokine theory. Miner Electrolyte Metab 21:317\u2013327","journal-title":"Miner Electrolyte Metab"},{"key":"1327_CR23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1749-6632.1995.tb44622.x","volume":"760","author":"DR Senger","year":"1995","unstructured":"Senger DR, Brown LF, Perruzzi CA, Papadopoulos-Sergiou A, Van de Water L (1995) Osteopontin at the tumor\/host interface. Functional regulation by thrombin-cleavage and consequences for cell adhesion. Ann N Y Acad Sci 760:83\u2013100","journal-title":"Ann N Y Acad Sci"},{"key":"1327_CR24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.271.5248.509","volume":"271","author":"GF Weber","year":"1996","unstructured":"Weber GF, Ashkar S, Glimcher MJ, Cantor H (1996) Receptor\u2013ligand interaction between CD44 and osteopontin (Eta-1). Science 271:509\u2013512","journal-title":"Science"},{"key":"1327_CR25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/jor.20750","volume":"27","author":"OD Kennedy","year":"2009","unstructured":"Kennedy OD, Brennan O, Rackard SM, Staines A, O'Brien FJ, Taylor D, Lee TC (2009) Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12\u00a0months postsurgery. J Orthop Res 27:303\u2013309","journal-title":"J Orthop Res"},{"issue":"1","key":"1327_CR26","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00223-002-1090-x","volume":"73","author":"SA Shapses","year":"2003","unstructured":"Shapses SA, Cifuentes M, Spevak L, Chowdhury H, Brittingham J, Boskey AL, Denhardt DT (2003) Osteopontin facilitates bone resorption, decreasing bone mineral crystallinity and content during calcium deficiency. Calcif Tissue Int 73(1):86\u201392","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"1327_CR27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1677\/joe.1.06704","volume":"193","author":"M Ishijima","year":"2007","unstructured":"Ishijima M, Tsuji K, Rittling SR, Yamashita T, Kurosawa H, Denhardt DT, Nifuji A, Ezura Y, Noda M (2007) Osteopontin is required for mechanical stress-dependent signals to bone marrow cells. J Endocrinol 193(2):235\u2013243","journal-title":"J Endocrinol"},{"issue":"1","key":"1327_CR28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/jbm.a.31081","volume":"83","author":"NB Kavukcuoglu","year":"2007","unstructured":"Kavukcuoglu NB, Denhardt DT, Guzelsu N, Mann AB (2007) Osteopontin deficiency and aging on nanomechanics of mouse bone. J Biomed Mater Res A 83(1):136\u2013144","journal-title":"J Biomed Mater Res A"},{"key":"1327_CR29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jor.20505","volume":"26","author":"RM McCann","year":"2008","unstructured":"McCann RM, Colleary G, Geddis C, Clarke SA, Jordan GR, Dickson GR, Marsh D (2008) Effect of osteoporosis on bone mineral density and fracture repair in a rat femoral fracture model. J Orthop Res 26:384\u2013393","journal-title":"J Orthop Res"},{"issue":"5","key":"1327_CR30","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1084\/jem.20071294","volume":"205","author":"L Malaval","year":"2008","unstructured":"Malaval L, Wade-Gu\u00e9ye NM, Boudiffa M, Fei J, Zirngibl R, Chen F, Laroche N, Roux JP, Burt-Pichat B, Duboeuf F, Boivin G, Jurdic P, Lafage-Proust MH, Am\u00e9d\u00e9e J, Vico L, Rossant J, Aubin JE (2008) Bone sialoprotein plays a functional role in bone formation and osteoclastogenesis. J Exp Med 205(5):1145\u20131153","journal-title":"J Exp Med"},{"issue":"6","key":"1327_CR31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.bone.2008.05.010","volume":"44","author":"H Yamane","year":"2009","unstructured":"Yamane H, Sakai A, Mori T, Tanaka S, Moridera K, Nakamura T (2009) The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice. Bone 44(6):1055\u20131062","journal-title":"Bone"},{"issue":"28","key":"1327_CR32","doi-asserted-by":"crossref","first-page":"19400","DOI":"10.1074\/jbc.M800005200","volume":"283","author":"N Ono","year":"2008","unstructured":"Ono N, Nakashima K, Rittling SR, Schipani E, Hayata T, Soma K, Denhardt DT, Kronenberg HM, Ezura Y, Noda M (2008) Osteopontin negatively regulates parathyroid hormone receptor signaling in osteoblasts. J Biol Chem 283(28):19400\u201319409","journal-title":"J Biol Chem"},{"issue":"6","key":"1327_CR33","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/S0002-9440(10)64482-3","volume":"161","author":"SA Steitz","year":"2002","unstructured":"Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM (2002) Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 161(6):2035\u20132046","journal-title":"Am J Pathol"},{"key":"1327_CR34","doi-asserted-by":"crossref","unstructured":"Chang IC, Chiang TY, Yah KT, Lee H, Cheng YW (2010) Increased serum osteopontin is a risk factor for osteoporosis in menopausal women. Osteoporosis Int (in press)","DOI":"10.1007\/s00198-009-1107-7"},{"key":"1327_CR35","first-page":"21","volume":"14","author":"M Wallace","year":"2008","unstructured":"Wallace M, Shelkey M (2008) Katz index of independence in activities of daily living. Assisted Living Consult 14:21\u201322","journal-title":"Assisted Living Consult"},{"key":"1327_CR36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2407-6-207","volume":"6","author":"D Vordermark","year":"2006","unstructured":"Vordermark D, Said HM, Katzer A, Kuhnt T, H\u00e4nsgen G, Dunst J, Flentje M, Bache M (2006) Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system. BMC Cancer 6:207","journal-title":"BMC Cancer"},{"issue":"3","key":"1327_CR37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.bbrc.2004.02.124","volume":"316","author":"T Ishii","year":"2004","unstructured":"Ishii T, Ohshima S, Ishida T, Mima T, Tabunoki Y, Kobayashi H, Maeda M, Uede T, Liaw L, Kinoshita N, Kawase I, Saeki Y (2004) Osteopontin as a positive regulator in the osteoclastogenesis of arthritis. Biochem Biophys Res Commun 316(3):809\u2013815","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"1327_CR38","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1074\/jbc.M209299200","volume":"278","author":"T Sugatani","year":"2003","unstructured":"Sugatani T, Alvarez U, Hruska KA (2003) PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motility. J Biol Chem 278(7):5001\u20135008","journal-title":"J Biol Chem"},{"issue":"4","key":"1327_CR39","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-0722.2008.00545.x","volume":"116","author":"CG Walker","year":"2008","unstructured":"Walker CG, Ito Y, Dangaria S, Luan X, Diekwisch TG (2008) RANKL, osteopontin, and osteoclast homeostasis in a hyperocclusion mouse model. Eur J Oral Sci 116(4):312\u2013318","journal-title":"Eur J Oral Sci"},{"key":"1327_CR40","first-page":"314","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"R Eastell","year":"2003","unstructured":"Eastell R (2003) Pathogenesis of postmenopausal osteoporosis. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 5th edn. American Society for Bone and Mineral Research, Washington DC, pp 314\u2013316","edition":"5"},{"key":"1327_CR41","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1359\/jbmr.2000.15.10.1965","volume":"15","author":"R Recker","year":"2000","unstructured":"Recker R, Lappe J, Davies K, Heaney R (2000) Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res 15:1965\u20131973","journal-title":"J Bone Miner Res"},{"key":"1327_CR42","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1359\/jbmr.2002.17.11.2061","volume":"17","author":"B Abrahamsen","year":"2002","unstructured":"Abrahamsen B, Nissen N, Hermann AP, Hansen B, B\u00e4renholdt O, Vestergaard P, Tofteng CL, Pors Nielsen S (2002) When should densitometry be repeated in healthy peri- and postmenopausal women?: the Danish osteoporosis prevention study. J Bone Miner Res 17:2061\u20132067","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1327_CR43","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/jcb.21121","volume":"100","author":"Y Li","year":"2007","unstructured":"Li Y, Li A, Yang X, Weitzmann MN (2007) Ovariectomy-induced bone loss occurs independently of B cells. J Cell Biochem 100(6):1370\u20131375","journal-title":"J Cell Biochem"},{"issue":"2","key":"1327_CR44","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1590\/S0100-879X2005000200004","volume":"38","author":"MC Bezerra","year":"2005","unstructured":"Bezerra MC, Carvalho JF, Prokopowitsch AS, Pereira RM (2005) RANK, RANKL and osteoprotegerin in arthritic bone loss. Braz J Med Biol Res 38(2):161\u2013170","journal-title":"Braz J Med Biol Res"},{"issue":"11","key":"1327_CR45","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1128\/IAI.00228-08","volume":"76","author":"SN Somayaji","year":"2008","unstructured":"Somayaji SN, Ritchie S, Sahraei M, Marriott I, Hudson MC (2008) Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts. Infect Immun 76(11):5120\u20135126","journal-title":"Infect Immun"},{"issue":"5","key":"1327_CR46","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S1016-8478(23)14027-1","volume":"26","author":"S Oh","year":"2008","unstructured":"Oh S, Kyung TW, Choi HS (2008) Curcumin inhibits osteoclastogenesis by decreasing receptor activator of nuclear factor-kappaB ligand (RANKL) in bone marrow stromal cells. Mol Cells 26(5):486\u2013489","journal-title":"Mol Cells"},{"issue":"3","key":"1327_CR47","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bone.2007.11.008","volume":"42","author":"D Seriwatanachai","year":"2008","unstructured":"Seriwatanachai D, Thongchote K, Charoenphandhu N, Pandaranandaka J, Tudpor K, Teerapornpuntakit J, Suthiphongchai T, Krishnamra N (2008) Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand\/osteoprotegerin ratio. Bone 42(3):535\u2013546","journal-title":"Bone"},{"issue":"5","key":"1327_CR48","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1359\/jbmr.081237","volume":"24","author":"DD Pierroz","year":"2009","unstructured":"Pierroz DD, Rufo A, Bianchi EN, Glatt V, Capulli M, Rucci N, Cavat F, Rizzoli R, Teti A, Bouxsein ML, Ferrari SL (2009) Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice. J Bone Miner Res 24(5):775\u2013784","journal-title":"J Bone Miner Res"},{"key":"1327_CR49","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1172\/JCI12980","volume":"107","author":"DT Denhardt","year":"2001","unstructured":"Denhardt DT, Noda M, O\u2019Regan AW, Pavlin D, Berman JS (2001) Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Investig 107:1055\u20131061","journal-title":"J Clin Investig"},{"key":"1327_CR50","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/(SICI)1097-4652(200007)184:1<118::AID-JCP13>3.0.CO;2-Y","volume":"184","author":"R Zohar","year":"2000","unstructured":"Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CA, Sodek J (2000) Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol 184:118\u2013130","journal-title":"J Cell Physiol"},{"key":"1327_CR51","doi-asserted-by":"crossref","first-page":"46024","DOI":"10.1074\/jbc.M105132200","volume":"276","author":"YH Lin","year":"2001","unstructured":"Lin YH, Yang-Yen HF (2001) The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase\/Akt signaling pathway. J Biol Chem 276:46024\u201346030","journal-title":"J Biol Chem"},{"issue":"2","key":"1327_CR52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1359\/jbmr.2001.16.2.277","volume":"16","author":"SL Cheng","year":"2001","unstructured":"Cheng SL, Lai CF, Blystone SD, Avioli LV (2001) Bone mineralization and osteoblast differentiation are negatively modulated by integrin alpha(v)beta3. J Bone Miner Res 16(2):277\u2013288","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1327_CR53","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","volume":"104","author":"RL Jilka","year":"1999","unstructured":"Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC (1999) Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104(4):439\u2013446","journal-title":"J Clin Invest"},{"issue":"3","key":"1327_CR54","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1172\/JCI116273","volume":"91","author":"AB Hodsman","year":"1993","unstructured":"Hodsman AB, Fraher LJ, Ostbye T, Adachi JD, Steer BM (1993) An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis. J Clin Invest 91(3):1138\u20131148","journal-title":"J Clin Invest"},{"issue":"5","key":"1327_CR55","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1359\/jbmr.2002.17.5.808","volume":"17","author":"A Iida-Klein","year":"2002","unstructured":"Iida-Klein A, Zhou H, Lu SS, Levine LR, Ducayen-Knowles M, Dempster DW, Nieves J, Lindsay R (2002) Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. J Bone Miner Res 17(5):808\u2013816","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1327-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-010-1327-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1327-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T20:55:14Z","timestamp":1711745714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-010-1327-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,24]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1327"],"URL":"https:\/\/doi.org\/10.1007\/s00198-010-1327-x","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,24]]}}}